Skip to main content
SpringerLink
Log in

Barrett’s Esophagus

  • Chapter
  • First Online:
Principles of Deglutition

Abstract

Barrett’s esophagus is the condition in which a metaplastic columnar mucosa that predisposes to cancer development replaces the stratified squamous mucosa that normally lines the distal esophagus. The condition develops as a complication of chronic gastroesophageal reflux disease (GERD), which is often severe in patients who have long segments of Barrett’s metaplasia extending up the esophagus. Barrett’s esophagus is a major risk factors for esophageal adenocarcinoma, a tumor whose frequency has increased more than six-fold over the past several decades. Because of this cancer risk, patients with Barrett’s esophagus are advised to have regular endoscopic surveillance with esophageal biopsy sampling to detect dysplasia, the precursor of invasive adenocarcinoma. Until recently, patients with high-grade dysplasia in Barrett’s esophagus were treated with esophagectomy. Today, most patients with high-grade dysplasia can be treated successfully with endoscopic eradication therapy. This chapter discusses the diagnosis, epidemiology, pathogenesis and management of Barrett’s esophagus.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett’s esophagus. Gastroenterology. 2010;138:854–69.

    Article  PubMed  Google Scholar 

  2. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–6.

    Article  PubMed  Google Scholar 

  3. Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology. 1999;117:218–28.

    Article  PubMed  CAS  Google Scholar 

  4. Spechler SJ, Goyal RK. The columnar lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology. 1996;110:614–21.

    Article  PubMed  CAS  Google Scholar 

  5. Chandrasoma P. Controversies of the cardiac mucosa and Barrett’s oesophagus. Histopathology. 2005;46:361–73.

    Article  PubMed  CAS  Google Scholar 

  6. Riddell RH, Odze RD. Definition of Barrett’s esophagus: time for a rethink—is intestinal metaplasia dead? Am J Gastroenterol. 2009;104:2588–94.

    Article  PubMed  Google Scholar 

  7. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Asso­ciation technical review on the management of Barrett’s esophagus. Gastroenterology. 2011;140:e18–52.

    Article  PubMed  Google Scholar 

  8. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994;344:1533–6.

    Article  PubMed  CAS  Google Scholar 

  9. Sharma P, Morales TG, Sampliner RE. Short segment Barrett’s esophagus. The need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998;93:1033–6.

    PubMed  CAS  Google Scholar 

  10. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GN, Vieth M. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–9.

    Article  PubMed  Google Scholar 

  11. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am. 1997;26:487–94.

    Article  PubMed  CAS  Google Scholar 

  12. Hassall E. Esophageal metaplasia: definition and prevalence in childhood. Gastrointest Endosc. 2006;64:676–7.

    Article  PubMed  Google Scholar 

  13. Spechler SJ. Barrett’s esophagus. N Engl J Med. 2002;346:836–42.

    Article  PubMed  Google Scholar 

  14. Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS, Dunne D, Rahmani EY, Helper DJ. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125:1670–7.

    Article  PubMed  Google Scholar 

  15. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agreus L. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastro­enterology. 2005;129:1825–31.

    Article  PubMed  Google Scholar 

  16. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology. 2000;119:333–8.

    Article  PubMed  CAS  Google Scholar 

  17. Sharma P. Clinical practice Barrett’s esophagus. N Engl J Med. 2009;361:2548–56.

    Article  PubMed  CAS  Google Scholar 

  18. Wani S, Falk G, Hall M, Gaddam S, Wang A, Gupta N, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Reddymasu S, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Lieberman DA, Sampliner RE, Sharma P. Patients with nondysplastic Barrett’s esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2011;9:220–7.

    Article  PubMed  Google Scholar 

  19. Spechler SJ. Barrett’s esophagus: an overrated cancer risk factor. Gastroenterology. 2000;119:587–9.

    Article  PubMed  CAS  Google Scholar 

  20. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31.

    Article  PubMed  CAS  Google Scholar 

  21. Chak A, Faulx A, Eng C, Grady W, Kinnard M, ­Ochs-Balcom H, Falk G. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Cancer. 2006;107:2160–6.

    Article  PubMed  Google Scholar 

  22. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199–211.

    PubMed  Google Scholar 

  23. El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR. Obesity increases oesophageal acid exposure. Gut. 2007;56:749–55.

    Article  PubMed  Google Scholar 

  24. Delaney B, McColl K. Review article: Helicobacter pylori and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005;22 Suppl 1:32–40.

    Article  PubMed  Google Scholar 

  25. Souza RF, Spechler SJ. Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA Cancer J Clin. 2005;55:334–51.

    Article  PubMed  Google Scholar 

  26. Iascone C, DeMeester TR, Little AG, Skinner DB. Barrett’s esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg. 1983;118:543–9.

    Article  PubMed  CAS  Google Scholar 

  27. Fletcher J, Wirz A, Young J, Vallance R, McColl KEL. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology. 2001;121:775–83.

    Article  PubMed  CAS  Google Scholar 

  28. Fletcher J, Wirz A, Henry E, McColl KEL. Studies of acid exposure immediately above the gastro-oesophageal junction: evidence of short segment reflux. Gut. 2004;53:168–73.

    Article  PubMed  CAS  Google Scholar 

  29. Iijima K, Henry E, Moriya A, Wirz A, Kelman AW, McColl KEL. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology. 2002;122:1248–57.

    Article  PubMed  CAS  Google Scholar 

  30. Spechler SJ. Intestinal metaplasia at the gastroesophageal junction. Gastroenterology. 2004;126:567–75.

    Article  PubMed  Google Scholar 

  31. Souza RF, Krishnan K, Spechler SJ. Acid, bile and CDX: the ABCs of making Barrett’s metaplasia. Am J Physiol Gastrointest Liver Physiol. 2008;295:G211–8.

    Article  PubMed  CAS  Google Scholar 

  32. Huo X, Zhang HY, Zhang XI, Lynch JP, Strauch ED, Wang JY, Melton SD, Genta RM, Wang DH, Spechler SJ, Souza RF. Differences in CDX2 expression after exposure to acid and bile salts in esophageal squamous cell lines from GERD patients with and without Barrett’s esophagus. Gastroenterology. 2010;139:194–203.

    Article  PubMed  CAS  Google Scholar 

  33. Sarosi G, Brown G, Jaiswal K, Feagins LA, Lee E, Crook TW, Souza RF, Zou YS, Shay JW, Spechler SJ. Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett’s esophagus. Dis Esophagus. 2008;21:43–50.

    PubMed  CAS  Google Scholar 

  34. Wang X, Ouyang H, Yamamoto Y, Kumar PA, Wei TS, Dagher R, Vincent M, Lu X, Bellizzi AM, Ho KY, Crum CP, Xian W, McKeon F. Residual embryonic cells as precursors of a Barrett’s-like metaplasia. Cell. 2011;145:1023–35.

    Article  PubMed  CAS  Google Scholar 

  35. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.

    Article  PubMed  CAS  Google Scholar 

  36. Fritcher EG, Brankley SM, Kipp BR, Voss JS, Campion MB, Morrison LE, Legator MS, Lutzke LS, Wang KK, Sebo TJ, Halling KC. A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett’s esophagus. Hum Pathol. 2008;39:1128–35.

    Article  PubMed  Google Scholar 

  37. American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–91.

    Article  PubMed  Google Scholar 

  38. Spechler SJ. Dysplasia in Barrett’s esophagus: limitations of current management strategies. Am J Gastroenterol. 2005;100:927–35.

    Article  PubMed  Google Scholar 

  39. Downs-Kelly E, Mendelin JE, Bennett AE, Castilla E, Henricks WH, Schoenfield L, Skacel M, Yerian L, Rice TW, Rybicki LA, Bronner MP, Goldblum JR. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett’s esophagus biopsies. Am J Gastroenterol. 2008;103:2333–40.

    Article  PubMed  Google Scholar 

  40. Kariv R, Plesec TP, Goldblum JR, Bronner M, Oldenburgh M, Rice TW, Falk GW. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol. 2009;7:653–8.

    Article  PubMed  Google Scholar 

  41. Kara MA, Peters FP, Ten Kate FJ, Van Deventer SJ, Fockens P, Bergman JJ. Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett’s esophagus. Gastrointest Endosc. 2005;61:679–85.

    Article  PubMed  Google Scholar 

  42. Collard JM. High-grade dysplasia in Barrett’s esophagus. The case for esophagectomy. Chest Surg Clin North Am. 2002;12:77–92.

    Article  Google Scholar 

  43. Konda VJ, Ross AS, Ferguson MK, Hart JA, Lin S, Naylor K, Noffsinger A, Posner MC, Dye C, Cislo B, Stearns L, Waxman I. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett’s esophagus overestimated? Clin Gastroenterol Hepatol. 2008;6:159–64.

    Article  PubMed  Google Scholar 

  44. Curvers WL, Bergman JJ. Multimodality imaging in Barrett’s esophagus: looking longer, seeing better, and recognizing more. Gastroenterology. 2008;135:297–9.

    Article  PubMed  Google Scholar 

  45. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006;4:566–72.

    Article  PubMed  Google Scholar 

  46. Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1413.e1–5.

    Google Scholar 

  47. Zhang HY, Hormi-Carver K, Zhang X, Spechler SJ, Souza RF. In benign Barrett’s epithelial cells, acid exposure generates reactive oxygen species that cause DNA double strand breaks. Cancer Res. 2009;69:9083–9.

    Article  PubMed  CAS  Google Scholar 

  48. Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett’s esophagus and the effects of acid suppression. Gastro­enterology. 1999;117:327–35.

    Article  PubMed  CAS  Google Scholar 

  49. Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Karrenbeld A, Jager-Krikken A, Klinkenberg-Knol EC, Lamers CB, Kleibeuker JH. Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus. Scand J Gastroenterol. 2000;35:1238–44.

    Article  PubMed  CAS  Google Scholar 

  50. Umansky M, Yasui W, Hallak A, Brill S, Shapira I, Halpern Z, Hibshoosh H, Rattan J, Meltzer S, Tahara E, Arber N. Proton pump inhibitors reduce cell cycle abnormalities in Barrett’s esophagus. Oncogene. 2001;20:7987–91.

    Article  PubMed  CAS  Google Scholar 

  51. El Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett’s esophagus. Am J Gastroenterol. 2004;99:1877–83.

    Article  PubMed  Google Scholar 

  52. Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett’s oesophagus. Med J Aust. 2004;180:387–91.

    PubMed  Google Scholar 

  53. Cooper BT, Chapman W, Neumann CS, Gearty JC. Continuous treatment of Barrett’s oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther. 2006;23:727–33.

    Article  PubMed  CAS  Google Scholar 

  54. Nguyen DM, El Serag HB, Henderson L, Stein D, Bhattacharyya A, Sampliner R. Medication usage and the risk of neoplasia in patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2009;7:1299–304.

    Article  PubMed  Google Scholar 

  55. Gerson LB, Boparai V, Ullah N, Triadafilopoulos G. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett’s oesophagus treated with proton pump inhibitors. Aliment Pharmacol Ther. 2004;20:637–43.

    Article  PubMed  CAS  Google Scholar 

  56. Spechler SJ, Sharma P, Traxler B, Levine D, Falk GW. Gastric and esophageal pH in patients with Barrett’s esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial. Am J Gastroenterol. 2006;101:1964–71.

    Article  PubMed  CAS  Google Scholar 

  57. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W. Long-term outcome of medical and surgical treatments for gastroesophageal reflux disease. Follow-up of a randomized controlled trial. J Am Med Assoc. 2001;285:2331–8.

    Article  CAS  Google Scholar 

  58. Ye W, Chow WH, Lagergren J, Yin L, Nyren O. Risk of adenocarcinoma of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology. 2001;121:1286–93.

    Article  PubMed  CAS  Google Scholar 

  59. Corey KE, Schmitz SM, Shaheen NJ. Does a surgical antireflux procedure decrease the incidence of ­esophageal adenocarcinoma in Barrett’s esophagus? A meta-analysis. Am J Gastroenterol. 2003;98:2390–4.

    Article  PubMed  Google Scholar 

  60. Tran T, Spechler SJ, El-Serag HB. Fundoplication and the risk of cancer in gastroesophageal reflux disease: a veterans affairs cohort study. Am J Gastroenterol. 2005;100:1002–8.

    Article  PubMed  Google Scholar 

  61. Chang EY, Morris CD, Seltman AK, O’Rourke RW, Chan BK, Hunter JG, Jobe BA. The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review. Ann Surg. 2007;246:11–21.

    Article  PubMed  Google Scholar 

  62. Spechler SJ. Screening and surveillance for Barrett’s esophagus—an unresolved dilemma. Nat Clin Pract Gastroenterol Hepatol. 2007;4:470–1.

    Article  PubMed  Google Scholar 

  63. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O’Connell S, Seidel UJ, Sonnenberg A. Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia. Gastroenterology. 2001;120:1607–19.

    Article  PubMed  CAS  Google Scholar 

  64. Karl RC, Schreiber R, Boulware D, Baker S, Coppola D. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor-Lewis esophagogastrectomy. Ann Surg. 2000;231:635–43.

    Article  PubMed  CAS  Google Scholar 

  65. de Boer AG, van Lanschot JJ, van Sandick JW, Hulscher JB, Stalmeier PF, de Haes JC, Tilanus HW, Obertop H, Sprangers MA. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol. 2004;22:4202–8.

    Article  PubMed  Google Scholar 

  66. Rice TW, Zuccaro G, Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg. 1998;65:787–92.

    Article  PubMed  CAS  Google Scholar 

  67. van Sandick JW, van Lanschot JJ, ten Kate FJ, Offerhaus GJ, Fockens P, Tytgat GN, Obertop H. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer. 2000;88:2429–37.

    Article  PubMed  Google Scholar 

  68. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520–30.

    Article  PubMed  CAS  Google Scholar 

  69. Rice TW, Blackstone EH, Goldblum JR, DeCamp MM, Murthy SC, Falk GW, Ormsby AH, Rybicki LA, Richter JE, Adelstein DJ. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg. 2001;122:1077–90.

    Article  PubMed  CAS  Google Scholar 

  70. Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc. 2004;60:703–10.

    Article  PubMed  Google Scholar 

  71. Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242:566–73.

    PubMed  Google Scholar 

  72. Liu L, Hofstetter WL, Rashid A, Swisher SG, Correa AM, Ajani JA, Hamilton SR, Wu TT. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol. 2005;29:1079–85.

    PubMed  Google Scholar 

  73. Westerterp M, Koppert LB, Buskens CJ, Tilanus HW, ten Kate FJ, Bergman JJ, Siersema PD, van Dekken H, van Lanschot JJ. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005;446:497–504.

    Article  PubMed  Google Scholar 

  74. Bollschweiler E, Baldus SE, Schröder W, Prenzel K, Gutschow C, Schneider PM, Hölscher AH. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy. 2006;38:149–56.

    Article  PubMed  CAS  Google Scholar 

  75. Oh DS, Hagen JA, Chandrasoma PT, Dunst CM, Demeester SR, Alavi M, Bremner CG, Lipham J, Rizzetto C, Cote R, Demeester TR. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg. 2006;203:152–61.

    Article  PubMed  Google Scholar 

  76. Peyre CG, DeMeester SR, Rizzetto C, Bansal N, Tang AL, Ayazi S, Leers JM, Lipham JC, Hagen JA, DeMeester TR. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Ann Surg. 2007;246:665–71.

    Article  PubMed  Google Scholar 

  77. Altorki NK, Lee PC, Liss Y, Meherally D, Korst RJ, Christos P, Mazumdar M, Port JL. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg. 2008;247:434–9.

    Article  PubMed  Google Scholar 

  78. Leers JM, DeMeester SR, Oezcelik A, Klipfel N, Ayazi S, Abate E, Zehetner J, Lipham JC, Chan L, Hagen JA, DeMeester TR. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg. 2011;253:271–8.

    Article  PubMed  Google Scholar 

  79. Larghi A, Lightdale CJ, Memeo L, Bhagat G, Okpara N, Rotterdam H. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett’s esophagus. Gastrointest Endosc. 2005;62:16–23.

    Article  PubMed  Google Scholar 

  80. Prasad GA, Buttar NS, Wongkeesong LM, Lewis JT, Sanderson SO, Lutzke LS, Borkenhagen LS, Wang KK. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett’s esophagus. Am J Gastroenterol. 2007;102:2380–6.

    Article  PubMed  Google Scholar 

  81. Ahmadi A, Draganov P. Endoscopic mucosal resection in the upper gastrointestinal tract. World J Gastroenterol. 2008;14:1984–9.

    Article  PubMed  Google Scholar 

  82. Peters FP, Kara MA, Curvers WL, Rosmolen WD, Fockens P, Krishnadath KK, Ten Kate FJ, Bergman JJ. Multiband mucosectomy for endoscopic resection of Barrett’s esophagus: feasibility study with matched historical controls. Eur J Gastroenterol Hepatol. 2007;19:311–5.

    Article  PubMed  Google Scholar 

  83. Soehendra N, Seewald S, Groth S, Omar S, Seitz U, Zhong Y, de Weerth A, Thonke F, Schroeder S. Use of modified multiband ligator facilitates circumferential EMR in Barrett’s esophagus (with video). Gastrointest Endosc. 2006;63:847–52.

    Article  PubMed  Google Scholar 

  84. Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A, Nachbar L, Huijsmans J, Vieth M, Stolte M. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc. 2007;65:3–10.

    Article  PubMed  Google Scholar 

  85. Brandt LJ, Kauvar DR. Laser-induced transient regression of Barrett’s epithelium. Gastrointest Endosc. 1992;38:619–22.

    Article  PubMed  CAS  Google Scholar 

  86. Spechler SJ, Souza RF. Biomarkers and photodynamic therapy for Barrett’s esophagus: time to FISH or cut bait? Gastroenterology. 2008;135:354–7.

    Article  PubMed  CAS  Google Scholar 

  87. Spechler SJ, Souza RF. Stem cells in Barrett’s esophagus: HALOs or horns? Gastrointest Endosc. 2008;68:41–3.

    Article  PubMed  Google Scholar 

  88. Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor SL, Grace MG, Depot M. International Photodynamic group for high-grade dysplasia in Barrett’s esophagus. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005;62:488–98.

    Article  PubMed  Google Scholar 

  89. Overholt BF, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak MV, Nishioka N, Barr H, Marcon N, Pedrosa M, Bronner MP, Grace M, Depot M. On behalf of the International Photodynamic Group for High-Grade Dysplasia in Barrett’s Esophagus. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc. 2007;66:460–8.

    Article  PubMed  Google Scholar 

  90. Fleischer DE, Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R, Chang KJ, Lightdale CJ, Santiago N, Pleskow DK, Dean PJ, Wang KK. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008;68:867–76.

    Article  PubMed  Google Scholar 

  91. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.

    Article  PubMed  CAS  Google Scholar 

  92. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, Manner H, Guenter E, Huijsmans J, Vieth M, Stolte M, Ell C. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut. 2008;57:1200–6.

    Article  PubMed  CAS  Google Scholar 

  93. Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Krishnadath KK, Nichols FC, Lutzke LS, Borkenhagen LS. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology. 2007;132:1226–33.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Dallas VA Medical Center, Berta M. and Cecil O. Patterson Chair in Gastroenterology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA

    Stuart Jon Spechler MD

Authors
  1. Stuart Jon Spechler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stuart Jon Spechler MD .

Editor information

Editors and Affiliations

  1. Div. Gastroenterology & Hepatology, Medical College of Wisconsin, West Wisconsin Avenue 9200, Milwaukee, 53226, Wisconsin, USA

    Reza Shaker

  2. , Dpt Otolaryngology/Head & Neck Surg., UC Davis Medical Center, Stockton Blvd. 2521, Sacramento, 95817, California, USA

    Peter C. Belafsky

  3. Ctr for Voice, Airway & Swallowing Disor, Department of Otolaryngology, Georgia Health Sciences University, 15th Street 1120, Augusta, 30912, Georgia, USA

    Gregory N. Postma

  4. , Dpt of Communication Sciences & Disorder, University of Wisconsin-Milwaukee, East Hartford Ave 2400, Milwaukee, 53201, Wisconsin, USA

    Caryn Easterling

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Spechler, S.J. (2013). Barrett’s Esophagus. In: Shaker, R., Belafsky, P., Postma, G., Easterling, C. (eds) Principles of Deglutition. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3794-9_49

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3794-9_49

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-3793-2

  • Online ISBN: 978-1-4614-3794-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation